Entering text into the input field will update the search result below

VIVUS, Inc. (VVUS) CEO John Amos on Q4 2019 Results - Earnings Call Transcript

Mar. 03, 2020 8:57 PM ETVIVUS, Inc. (VVUS) Stock2 Comments
SA Transcripts profile picture
SA Transcripts

VIVUS, Inc. (NASDAQ:VVUS) Q4 2019 Results Conference Call March 3, 2020 4:30 PM ET

Company Participants

David Carey - Senior Partner, Lazar FINN Partners

John Amos - CEO

Mark Oki - CFO

Dr. Santosh Varghese - Chief Medical Officer

Conference Call Participants

John Vandermosten - Zacks

Chuck Whitesell - Wells Fargo Securities


Good afternoon. And welcome to the VIVUS Fourth Quarter and Full Year 2019 Financial Results Conference Call. [Operator Instructions] Today’s call is being recorded. An accompanying slide deck is available on today’s webcast and also available on the Presentations page of the VIVUS Investor Relations website.

For introductions and opening remarks, I’d like to turn the call over to Mr. David Carey with Lazar FINN Partners. Please go ahead.

David Carey

Thank you, operator. Good afternoon, everyone, and welcome to today’s teleconference. With me on the call is John Amos, VIVUS’ Chief Executive Officer; Mark Oki, Chief Financial Officer; and Dr. Santosh Varghese, VIVUS’ Chief Medical Officer.

Before we get started, I would like to remind everyone that during this conference call, VIVUS will make certain statements that are considered forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. As noted on slide two, these statements may be identified by the use of forward-looking words such as anticipate, believe, estimate, expect, forecast, intend, hope, likely, may, opportunity, plan, potential, predict and should among others. These forward-looking statements are based on VIVUS’ current expectations and actual results could differ materially.

There are number of factors that could cause actual events to differ mentally from those indicated by such forward-looking statements. Investors are advised to read the risk factors set forth in VIVUS’ Form 10-K for the year ended December 31, 2019, which was filed earlier today, March 30, 2020 as well as periodic reports filed with the Securities and Exchange

Recommended For You

Comments (2)

I’ve waited years for this company to do Something. My worst stock investment.
User 12690101 profile picture
Don't worry.... You are not the only 1 out there. Good luck!
To report an error in this transcript, .Contact us to add your company to our coverage or use transcripts in your business. Learn more about Seeking Alpha transcripts here. Your feedback matters to us!

More on VVUS

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.